|

Nonavalent HPV vaccine (9vHPV/Gardasil-9™). Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Miquel Angel Pavon Ribas1

Indications

  • HPV-16/ 181
  • Human Papillomavirus (HPV) Infections1
  • Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)1
  • High Risk HPV1
  • Cancer1

Other1 trial

A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.